FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thierry Conroy

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Questionnaires

Disorders

Geographic Areas

France

Co-author Network

Publications

TOP 3
Joachim Weis; Markus Wirtz; Juan Ignacio Arraras; Thierry Conroy; Fabio Efficace; Henning Flechtner; Claudia Fleissner; Attila Görög; Eva Hammerlid; Bernhard Holzner; Louise Jones; Anne Lanceley; Susanne Singer; Andrew Bottomley
Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
Morten Aa Petersen; Susanne Singer; Galina Velikova; Irma M Verdonck-de Leeuw; Teresa Young; Neil K Aaronson; Juan Ignacio Arraras; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Johannes M Giesinger; Mogens Groenvold; Bernhard Holzner; Madeleine T King
The EORTC computer-adaptive tests measuring physical functioning and fatigue exhibited high levels of measurement precision and efficiency.
Sophie Gourgou-Bourgade; Rosine Guimbaud; Jean-Luc Raoul; Marc Ychou; Antoine Adenis; Caroline Bascoul-Mollevi; Yves Bécouarn; Jocelyne Bérille; Valérie Boige; Olivier Bouché; Françoise Desseigne; Thierry Conroy
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thierry Conroy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joachim Weis; Markus Wirtz; Juan Ignacio Arraras; Thierry Conroy; Fabio Efficace; Henning Flechtner; Claudia Fleissner; Attila Görög; Eva Hammerlid; Bernhard Holzner; Louise Jones; Anne Lanceley; Susanne Singer; Andrew Bottomley
Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).
Psycho-oncology 2013;22(5):1002-7.
2013: Morten Aa Petersen; Susanne Singer; Galina Velikova; Irma M Verdonck-de Leeuw; Teresa Young; Neil K Aaronson; Juan Ignacio Arraras; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Johannes M Giesinger; Mogens Groenvold; Bernhard Holzner; Madeleine T King
The EORTC computer-adaptive tests measuring physical functioning and fatigue exhibited high levels of measurement precision and efficiency.
Journal of clinical epidemiology 2013;66(3):330-9.
2013: Sophie Gourgou-Bourgade; Rosine Guimbaud; Jean-Luc Raoul; Marc Ychou; Antoine Adenis; Caroline Bascoul-Mollevi; Yves Bécouarn; Jocelyne Bérille; Valérie Boige; Olivier Bouché; Françoise Desseigne; Thierry Conroy
Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(1):23-9.
2013: Anne Rullier; Isabelle Soubeyran; Laurent Tisseau; Jocelyne Bérille; Frédéric Bibeau; Catherine Chassagne-Clément; Thierry Conroy; Bernard Denis; Marie-Agnès Diebold; Francette Ettore; Sophie Gourgou-Bourgade; Christophe Hennequin; Marta Jarlier; Isabelle Kleinclaus; Anne-Isabelle Lemaistre; Agnès Leroux; Laurent Mineur; Jean-François Mosnier; Norbert Padilla; Michel Peoc'h; Christophe Petitjean; Yves-Marie Robin; Jean-Pierre Gérard
Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12/0405 PRODIGE 2.
European journal of cancer (Oxford, England : 1990) 2013;49(1):82-9.
2012: Jean-Pierre Gérard; Sophie Gourgou-Bourgade; Christophe Hennequin; Béata Juzyna; Gérard Lledo; Marc-André Mahé; Isabelle Martel-Lafay; Laurent Mineur; Xavier Mirabel; Jean-François Seitz; V Vendrely; David Azria; Yves Bécouarn; Laurent Bedenne; Jean-François Berdah; Olivier Bouché; Guy de La Roche; Bernard Denis; Olivier Dupuis; Pierre-Luc Etienne; Eric François; Thierry Conroy
Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(36):4558-65.
2012: Christophe Le Tourneau; Anne-Lise Pouliquen; Thomas Rio Frio; Nicolas Servant; Marc-Henri Stern; Olivier Trédan; Anne Vincent-Salomon; Sébastien Armanet; Mario Campone; Thierry Conroy; Jean-Pierre Delord; David Gentien; Anthony Goncalves; Nicolas Isambert; Maud Kamal; Anne-Gaëlle Le Corroller; Xavier Paoletti
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial.
Targeted oncology 2012;7(4):253-65.
2012: Didier Peiffert; Jean-François Seitz; Laetitia Tournier-Rangeard; Antoine Adenis; Olivier Bouché; Thierry Conroy; F Cvitkovic; Bernard Denis; Eric François; Jean-Pierre Gérard; Marc Giovannini; Jean-Michel Hannoun-Lévi; Christophe Hennequin; Claire Lemanski; Elisabeth Luporsi; Antoine Lusinchi; Xavier Mirabel; Christine Montoto-Grillot; Françoise Mornex; Michel Ducreux
Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(16):1941-8.
2012: D Malka; Jean-Yves Pierga; N Vimond; E François; Marie-Pierre Galais; P Guichard; N Jacques; Antoine Adenis; V Boige; Eveline Boucher; B Chauffert; Thierry Conroy; F Cvitkovic; Michel Ducreux; Françoise Farace
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(4):919-27.
2011: Thierry Conroy; Céline Gavoille; Antoine Adenis
Metastatic pancreatic cancer: old drugs, new paradigms.
Current opinion in oncology 2011;23(4):390-5.
2011: Morten Aa Petersen; Mogens Groenvold; Neil K Aaronson; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Peter M Fayers; Jorunn Helbostad; Bernhard Holzner; Stein Kaasa; Susanne Singer; Galina Velikova; Teresa Young
Development of computerized adaptive testing (CAT) for the EORTC QLQ-C30 physical functioning dimension.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2011;20(4):479-90.
2011: Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thierry Conroy; Antoine Adenis; Roger Faroux; Christine Rebischung; Loic Bergougnoux; Leila Kockler; Jean-Yves Douillard
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer.
International journal of cancer. Journal international du cancer 2011;128(3):682-90.
2010: Morten Aa Petersen; Mogens Groenvold; Neil K Aaronson; Wei-Chu Chie; Thierry Conroy; Anna Costantini; Peter M Fayers; Jorunn Helbostad; Bernhard Holzner; Stein Kaasa; Susanne Singer; Galina Velikova; Teresa Young
Development of computerised adaptive testing (CAT) for the EORTC QLQ-C30 dimensions - general approach and initial results for physical functioning.
European journal of cancer (Oxford, England : 1990) 2010;46(8):1352-8.
2009: R N Whistance; Thierry Conroy; Wei-Chu Chie; A Costantini; Orhan Sezer; M Koller; C D Johnson; S A Pilkington; J Arraras; Edgar Ben-Josef; A M Pullyblank; Peter M Fayers; Jane M Blazeby
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2009;45(17):3017-26.
2009: Jane M Blazeby; Peter M Fayers; Thierry Conroy; Orhan Sezer; J Ramage; M Rees
Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases.
The British journal of surgery 2009;96(3):291-8.
2007: Pernilla Lagergren; Peter M Fayers; Thierry Conroy; Hubert J Stein; Orhan Sezer; Richard Hardwick; Eva Hammerlid; andrew bottomley; Eric Van Cutsem; Jane M Blazeby
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach.
European journal of cancer (Oxford, England : 1990) 2007;43(14):2066-73.
2007: S Gujral; Thierry Conroy; C Fleissner; O Sezer; PM King; Kerry Avery; P Sylvester; M Koller; M A G Sprangers; Jane M Blazeby
Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire.
European journal of cancer (Oxford, England : 1990) 2007;43(10):1564-73.
2007: Laurent Bedenne; Pierre Michel; Olivier Bouché; Chantal Milan; Christophe Mariette; Thierry Conroy; Denis Pezet; Bernard Roullet; Jean-François Seitz; Jean-Philippe Herr; Bernard Paillot; Patrick Arveux; Franck bonnetain; Christine Binquet
Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(10):1160-8.
2007: Anne Brédart; Corneel Coens; Neil Aaronson; Wei-Chu Chie; Fabio Efficace; Thierry Conroy; Jane M Blazeby; Eva Hammerlid; M Costantini; F Joly; Simon Schraub; Orhan Sezer; Juan Ignacio Arraras; C Rodary; A Costantini; M Mehlitz; Darius Razavi; andrew bottomley
Determinants of patient satisfaction in oncology settings from European and Asian countries: preliminary results based on the EORTC IN-PATSAT32 questionnaire.
European journal of cancer (Oxford, England : 1990) 2007;43(2):323-30.
2006: Jean-Pierre Gérard; Thierry Conroy; Franck bonnetain; Olivier Bouché; Olivier Chapet; Marie-Thérèse Closon-Dejardin; Michel Untereiner; Bernard Leduc; Eric Francois; Jean Maurel; Jean-François Seitz; Bruno Buecher; Rémy Mackiewicz; Michel Ducreux; Laurent Bedenne
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(28):4620-5.
2006: Franck bonnetain; Olivier Bouché; P Michel; C Mariette; Thierry Conroy; Denis Pezet; Bernard Roullet; Jean-François Seitz; Bernard Paillot; Patrick Arveux; Chantal Milan; Laurent Bedenne
A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(5):827-34.
2006: Rollon Poinsot; A Altmeyer; Thierry Conroy; Alexia Savignoni; Bernard Asselain; I Léonard; Eliane Marx; M Cosquer; M Sévellec; Jane A Gledhill; C Rodary; Mariette Mercier; P Dickès; M Fabbro; Pascal Antoine; Stephane Guerif; Simon Schraub; Sylvie Dolbeault; Anne Brédart
[Multisite validation study of questionnaire assessing out-patient satisfaction with care questionnaire in ambulatory chemotherapy or radiotherapy treatment].
Bulletin du cancer 2006;93(3):315-27.
2006: Thierry Conroy; A Adeni; Olivier Bouché; Yacine Merrouche; Emmanuel Mitry; Guillaume Gory-Delabaere
[Recommendations for clinical practice: management with first-line palliative chemotherapy for patients with metastatic colorectal cancer].
Bulletin du cancer 2006;93(2):197-200.
2006: Thierry Conroy; Frédéric Marchal; Jane M Blazeby
Quality of life in patients with oesophageal and gastric cancer: an overview.
Oncology 2006;70(6):391-402.
2006: Fabio Efficace; andrew bottomley; Corneel Coens; Kristel van Steen; Thierry Conroy; Patrick Schöffski; Hans Schmoll; Eric Van Cutsem; Claus-Henning Köhne
Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?
European journal of cancer (Oxford, England : 1990) 2006;42(1):42-9.
2005: Eric François; Marc Ychou; Michel Ducreux; Frédérique Bertheault-Cvitkovic; Marc Giovannini; Thierry Conroy; Claire Lemanski; Olivier Thomas; Valérie Magnin
Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study.
European journal of cancer (Oxford, England : 1990) 2005;41(18):2861-7.
2005: Franck bonnetain; Olivier Bouché; Thierry Conroy; Patrick Arveux; Jean-Luc Raoul; Marc Giovannini; Pierre-Luc Etienne; Emmanuel Mitry; Jean-François Seitz; Philippe Rougier; Cécile Girault; Laurent Bedenne
Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncology.
Gastroentérologie clinique et biologique 2005;29(11):1113-24.
2005: Anne Brédart; V Mignot; A Rousseau; Sylvie Dolbeault; N Beauloye; V Adam; Caroline Elie; I Leonard; Bernard Asselain; Thierry Conroy
[Cancer patient's satisfaction assessment using the EORTC QLQ-SAT32: comparison between self-assessment and interview response].
Revue d'épidémiologie et de santé publique 2005;53 Spec No 1():1S31-8.
2005: Anne Brédart; andrew bottomley; Jane M Blazeby; Thierry Conroy; Corneel Coens; Sven D'haese; Wei-Chu Chie; Eva Hammerlid; Juan Ignacio Arraras; Fabio Efficace; C Rodary; Simon Schraub; M Costantini; A Costantini; F Joly; Orhan Sezer; Darius Razavi; M Mehlitz; M Bielska-Lasota; Neil Aaronson
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32).
European journal of cancer (Oxford, England : 1990) 2005;41(14):2120-31.
2005: Bernard Nordlinger; Philippe Rougier; Jean-Pierre Arnaud; Muriel Debois; Jacques A Wils; Jean-Claude Ollier; Olivier Grobost; Philippe Lasser; Jacob Wals; Jerome Lacourt; Jean-François Seitz; Jose Guimares dos Santos; Harry Bleiberg; Rémy Mackiewickz; Thierry Conroy; Olivier Bouché; Thierry Morin; Liliana Baila; Eric Van Cutsem; Laurent Bedenne
Adjuvant regional chemotherapy and systemic chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a multicentre randomised controlled phase III trial.
The lancet oncology 2005;6(7):459-68.
2005: Marc Ychou; Guillaume Gory-Delabaere; Pierre Blanc; Lise Bosquet; Jacqueline Duffour; Marc Giovannini; François Guillemin; Claire Lemanski; Frédéric Marchal; Bruno Masson; Yacine Merrouche; Geneviève Monges; Antoine Adenis; Jean-François Bosset; Olivier Bouché; Thierry Conroy; Denis Pezet; Jean-Pierre Triboulet
[Clinical Practice Guidelines 2004. Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach: radiotherapy (therapeutic evaluation)].
Bulletin du cancer 2005;92(4):381-409.
2005: Thierry Conroy; Bernard Paillot; Eric François; Roland Bugat; Jacques-Henri Jacob; Ulrich Stein; Salvador Nasca; Jean-Philippe Metges; Olivier Rixe; Pierre Michel; Emmanuelle Magherini; Aliette Hua; Gael Deplanque
Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(6):1228-36.
2004: Thierry Conroy; Guillaume Gory-Delabaere; Antoine Adenis; Lise Bosquet; Olivier Bouché; Christophe Louvet; Emmanuel Mitry; Yves Bécouarn; Jean-François Bosset; Michel Ducreux; Pierre-Luc Etienne; Yacine Merrouche; Geneviève Monges; Philippe Rougier
[Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)].
Bulletin du cancer 2004;91(10):759-68.
2004: Jane M Blazeby; Thierry Conroy; andrew bottomley; Craig W Vickery; Juan Ignacio Arraras; Orhan Sezer; J Moore; M Koller; N S Turhal; R Stuart; Eric Van Cutsem; Sven D'haese; Corneel Coens
Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2260-8.
2004: Thierry Conroy; Mariette Mercier; Jacques Bonneterre; Elisabeth Luporsi; J L Lefebvre; Michel Lapeyre; Marc Puyraveau; Simon Schraub
French version of FACT-G: validation and comparison with other cancer-specific instruments.
European journal of cancer (Oxford, England : 1990) 2004;40(15):2243-52.
2004: Anne Brédart; V Mignot; A Rousseau; Sylvie Dolbeault; N Beauloye; V Adam; Caroline Elie; I Léonard; Bernard Asselain; Thierry Conroy
Validation of the EORTC QLQ-SAT32 cancer inpatient satisfaction questionnaire by self- versus interview-assessment comparison.
Patient education and counseling 2004;54(2):207-12.
2004: Philippe Rauch; Joelle Miny; Thierry Conroy; Lionel Neyton; Francis Guillemin
Quality of life among disease-free survivors of rectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):354-60.
2003: Thierry Conroy; Jane M Blazeby
Health-related quality of life in colorectal cancer patients.
Expert review of anticancer therapy 2003;3(4):493-504.
2003: Jane M Blazeby; Thierry Conroy; Eva Hammerlid; Peter M Fayers; Orhan Sezer; M Koller; Juan Ignacio Arraras; andrew bottomley; Craig W Vickery; Pierre-Luc Etienne; Derek Alderson
Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(10):1384-94.
2003: Morten Aa Petersen; Mogens Groenvold; Jakob B Bjorner; Neil Aaronson; Thierry Conroy; Ann Cull; Peter M Fayers; Marianne J Hjermstad; Mirjam Sprangers; Marianne Sullivan
Use of differential item functioning analysis to assess the equivalence of translations of a questionnaire.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2003;12(4):373-85.
2003: Vasia Kavadas; Jane M Blazeby; Thierry Conroy; O Sezer; B Holzner; M Koller; J Buckels
Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer.
European journal of cancer (Oxford, England : 1990) 2003;39(9):1259-63.
2003: Marc Ychou; Thierry Conroy; Jean-François Seitz; Sophie Gourgou; Aliette Hua; D Mery-Mignard; Andrew Kramar
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):481-9.
2003: Thierry Conroy; H Bleiberg; B Glimelius
Quality of life in patients with advanced colorectal cancer: what has been learnt?
European journal of cancer (Oxford, England : 1990) 2003;39(3):287-94.
2002: Nicolas Pourel; Didier Peiffert; Eric Lartigau; Emmanuel DESANDES; Elisabeth Luporsi; Thierry Conroy
Quality of life in long-term survivors of oropharynx carcinoma.
International journal of radiation oncology, biology, physics 2002;54(3):742-51.
2002: Jean-François Seitz; Jaafar Bennouna; Bernard Paillot; Erick Gamelin; Eric François; Thierry Conroy; Jean-Luc Raoul; Y Becouarn; Frédérique Bertheault-Cvitkovic; Marc Ychou; Salvador Nasca; A Fandi; P Barthelemy; Jean-Yves Douillard
Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1072-9.
2002: Thierry Conroy; Pierre-Luc Etienne; Antoine Adenis; Michel Ducreux; Bernard Paillot; J Oliveira; Jean-François Seitz; Eric Francois; Eric Van Cutsem; D J Th Wagener; F Kohser; S Daamen; M Praet; Thierry Gorlia; Benoît Baron; Jacques A Wils
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(5):721-9.
2002: Thierry Conroy
Activity of vinorelbine in gastrointestinal cancers.
Critical reviews in oncology/hematology 2002;42(2):173-8.
2002: Simon Schraub; Mariette Mercier; Thierry Conroy
[Quality of life measurement in cancer survivors].
Bulletin du cancer 2002;89(3):267-74.
2001: N Eche; Marie-France Pichon; V Quillien; Guillaume Gory-Delabaere; Jean-Marc Riedinger; Jean-Pierre Basuyau; Alain Daver; Bruno Buecher; Thierry Conroy; Lise Dieu; Jean-Michel Bidart; L Deneux
[Standards, options and recommendations for tumor markers in colorectal cancer].
Bulletin du cancer 2001;88(12):1177-206.
2001: R Lamy; Thierry Conroy; laurent brunaud; Laurent Bresler
[Tamoxifen for metastatic pancreatic adenocarcinoma: a complete response].
Gastroentérologie clinique et biologique 2001;25(10):912-3.
2001: Craig W Vickery; Jane M Blazeby; Thierry Conroy; Juan Ignacio Arraras; Orhan Sezer; M Koller; D Rosemeyer; Colin D Johnson; Derek Alderson
Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer.
European journal of cancer (Oxford, England : 1990) 2001;37(8):966-71.
2001: Didier Peiffert; M Giovannini; Michel Ducreux; P Michel; Eric François; Claire Lemanski; X Mirabel; F Cvitkovic; Elisabeth Luporsi; Thierry Conroy; Jean-Pierre Gérard
High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: final results of a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):397-404.
2001: Philippe Rauch; P Bey; D Peiffert; Thierry Conroy; Laurent Bresler
Factors affecting local control and survival after treatment of carcinoma of the rectum by endocavitary radiation: a retrospective study of 97 cases.
International journal of radiation oncology, biology, physics 2001;49(1):117-24.
2000: Jean-François Seitz; Chantal Milan; Marc Giovannini; F Dumas; J M Cauvin; Thierry Conroy; Eric François; P Renard; A Votte-Lambert; Bernard Paillot; Laurent Bedenne
[Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
Gastroentérologie clinique et biologique 2000;24(2):201-10.
1999: Thierry Conroy; Bernard Paillot; Antoine Adenis
[New drugs in gastrointestinal oncology. Current status and future directions].
Gastroentérologie clinique et biologique 1999;23(11):1145-65.
1999: Jean-Claude Barbare; Laurent Bedenne; Olivier Bouché; Guillaume Cadiot; Gilles Calais; Loïk de Calan; Thierry Conroy; Michel Ducreux; Pierre-Luc Etienne; D Elias; J Faivre; Jean-Louis Legoux; Philippe Maingon; F Mornex; Bernard Nordlinger; Jean-Claude Ollier; Didier Peiffert; G Pelletier; P Rat; Philippe Rougier; A Ruskone-Fourmestraux; Jean-François Seitz; J P Triboulet; Jean-Claude Trinchet; Marc Ychou
[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)].
Gastroentérologie clinique et biologique 1999;23(5):486-96.
1999: Jean-Claude Barbare; Laurent Bedenne; Olivier Bouché; Guillaume Cadiot; Gilles Calais; Loïk de Calan; Thierry Conroy; Michel Ducreux; Pierre-Luc Etienne; D Elias; J Faivre; Jean-Louis Legoux; Philippe Maingon; F Mornex; Bernard Nordlinger; Jean-Claude Ollier; Didier Peiffert; G Pelletier; P Rat; Philippe Rougier; A Ruskone-Fourmestraux; Jean-François Seitz; J P Triboulet; Jean-Claude Trinchet; Marc Ychou
[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)].
Gastroentérologie clinique et biologique 1999;23(4):502-12.
1999: Thierry Conroy; Philippe Rauch; François Guillemin
[Quality of life in patients with colorectal cancer].
Gastroentérologie clinique et biologique 1999;23(4):489-501.
1998: M C Kaminsky-Forrett; Thierry Conroy; Elisabeth Luporsi; Didier Peiffert; Michel Lapeyre; Patrick Boissel; F Guillemin; Pierre Bey
Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer.
International journal of radiation oncology, biology, physics 1998;42(5):935-41.
1998: Laurent Bedenne; Jean-François Seitz; Chantal Milan; P Renard; Jean Fraisse; Thierry Conroy; J Lacourt; P Janoray; Jean Faivre
[Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study].
Gastroentérologie clinique et biologique 1998;22(3):273-81.
1998: Thierry Conroy; Antoine Adenis
[Standards, Options, and Recommendations for the surveillance after treatment in cancer of the colon. The SOR Working Group "Cancer du Côlon" de la Fédération Nationale des Centres de Lutte Contre le Cancer].
Bulletin du cancer 1998;85(2):152-9.
1997: Harry Bleiberg; Thierry Conroy; Bernard Paillot; AJ Lacave; Geert H Blijham; Jacques-Henri Jacob; Laurent Bedenne; M Namer; P De Besi; F Gay; L Collette; TM Sahmoud
Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1216-20.
1997: Thierry Conroy; Joseph Stines
[Diagnosis of local recurrences and metastases from colorectal cancers].
La Revue du praticien 1997;47(12 Spec No):S7-13.
1997: Didier Peiffert; Jean-François Seitz; Philippe Rougier; Eric François; F Cvitkovic; X Mirabel; Salvador Nasca; Michel Ducreux; J M Hannoun-Levi; Antoine Lusinchi; E Debrigode; Thierry Conroy; Jean-Pierre Pignon; Jean-Pierre Gérard
Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):575-81.
1997: Philippe Rougier; Roland Bugat; Jean-Yves Douillard; Stéphane Culine; E Suc; P Brunet; Y Becouarn; Marc Ychou; Michel Marty; Jean-Marc Extra; Jacques Bonneterre; Antoine Adenis; Jean-François Seitz; Gérard Ganem; Moïse Namer; Thierry Conroy; Sylvie Negrier; Yacine Merrouche; F Burki; Mireille Mousseau; P Herait; Mondher Mahjoubi
Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(1):251-60.
1996: D J Wagener; W J Hoogenraad; Philippe Rougier; Antoine Lusinchi; B G Taal; C H Veenhof; A de Graeff; Thierry Conroy; Desmond Curran; TM Sahmoud; Jacques A Wils
Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
European journal of cancer (Oxford, England : 1990) 1996;32A(8):1310-3.
1996: Bruno Audhuy; P Cappelaere; M Martin; Andrés Cervantes; Michel Fabbro; A Rivière; David Khayat; H Bleiberg; M Faraldi; N Claverie; Enrique Aranda; Gérard Auclerc; B Audhuy; A Benhammouda; H Bleiberg; L Cals; P Cappelaere; A Cattan; A Cervantes; Bernard Chevallier; Thierry Conroy; Didier Cupissol; J De Grève; Eduardo Diaz-Rubio; J F Seitz
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapy.
European journal of cancer (Oxford, England : 1990) 1996;32A(5):807-13.
1996: Thierry Conroy; P L Etienne; Antoine Adenis; D J Wagener; Bernard Paillot; Eric François; Laurent Bedenne; J H Jacob; J F Seitz; Harry Bleiberg; C Van Pottelsberghe; Martine Van Glabbeke; F M Delgado; S Merle; Jacques A Wils
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):164-70.
1995: Muriel Barberi-Heyob; Jean-Louis Merlin; M Vigneron; Thierry Conroy
Addition of heparin in 5-fluorouracil solution for portal vein infusion has no influence on its stability under clinically relevant conditions.
Anti-cancer drugs 1995;6(1):163-4.
1995: Mohamed Hebbar; Jacques Bonneterre; Charles Fournier; L Vanlemmens; J M Pion; Antoine Adenis; E Kamus; B Hecquet; Thierry Conroy; M Tubiana-Hulin
Randomized trial comparing conventional intravenous bolus FEC and FEC with high-dose infusional 5-fluorouracil as first-line treatment of advanced breast cancer.
The Journal of infusional chemotherapy 1995;5(4):201-5.
1994: Thierry Conroy; F Guillemin; Joseph Stines; B Denis
[Diagnosis and staging of colorectal cancers].
La Revue du praticien 1994;44(20):2706-13.
1994: R Fety; F Rolland; Muriel Barberi-Heyob; Jean-Louis Merlin; Thierry Conroy; A Hardouin; A Riviere; Gérard Milano
Clinical randomized study of 5FU monitoring versus standard dose in patients with head and neck cancer: preliminary results.
Anticancer research 1994;14(6A):2347-52.
1994: Thierry Conroy; P Cappelaere; Michel Fabbro; A A Fauser; T A Splinter; M Spielmann; M Schneider; Bernard Chevallier; A Goupil; J Chauvergne
Acute antiemetic efficacy and safety of dolasetron mesylate, a 5-HT3 antagonist, in cancer patients treated with cisplatin. European Dolasetron Study Group.
American journal of clinical oncology 1994;17(2):97-102.
1993: Thierry Conroy; L Geoffrois; F Guillemin; Elisabeth Luporsi; I Krakowski; D Spaëth; V Frasie; D Volff
Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma.
Cancer 1993;72(7):2190-7.
1993: E J Roelofs; D J Wagener; Thierry Conroy; Jacques A Wils; J T Burghouts; M Fickers; A de Graeff; F Lalisang; Bernard Paillot
Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(5):426-8.
1993: D Spaeth; Thierry Conroy; I Krakowski; L Geoffrois; Elisabeth Luporsi; M Rios; B Weber
[Long term continuous combination of cisplatin and 5 fluorouracil in advanced breast neoplasms. A retrospective study of 77 patients].
Bulletin du cancer 1993;80(4):351-6.
1993: Thierry Conroy; Jacques A Wils; Bernard Paillot; D J Wagener; J T Burghouts; M M Fickers; A de Graeff; F M Lalisang
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers].
Bulletin du cancer 1993;80(3):255-60.
1993: Thierry Conroy; C Platini; Ph Troufléau; D Dartois; Elisabeth Luporsi; L Malissard; M Jannot; J Watelet; Joseph Stines
[Clinical presentation and prognostic factors in the diagnosis of bone metastases. Apropos of a series of 578 cases].
Bulletin du cancer 1993;80(10 Suppl):16-22.
1992: C Allavena; Thierry Conroy; Pierre Aletti; Pierre Bey; Pierre Lederlin
Late cardiopulmonary toxicity after treatment for Hodgkin's disease.
British journal of cancer 1992;65(6):908-12.
1992: C Platini; B Weber; Thierry Conroy; M J Ennen-Simard
[Chemotherapy of malignant ovarian Brenner tumors. Review of the literature apropos of 2 histological complete remissions after polychemotherapy].
Bulletin du cancer 1992;79(10):963-7.
1991: Jacques A Wils; H O Klein; D J Wagener; H Bleiberg; H Reis; Friedrich Korsten; Thierry Conroy; M Fickers; S Leyvraz; Marc Buyse
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(5):827-31.
1991: L Bresler; Patrick Boissel; Thierry Conroy; J Grosdidier
Pancreatic islet cell carcinoma with hypercalcemia: complete remission 5 years after surgical excision and chemotherapy.
The American journal of gastroenterology 1991;86(5):635-8.
1991: Bruno Chauffert; J F Seitz; Laurent Bedenne; P Renard; Thierry Conroy; P Rougier
Phase II evaluation of doxorubicin plus amiodarone in advanced hepatocarcinoma.
Gastroentérologie clinique et biologique 1991;15(10):774-5.
1989: Didier Peiffert; P Bey; Pierre Lederlin; Thierry Conroy; Francis Witz
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].
Bulletin du cancer 1989;76(4):373-82.
1988: Thierry Conroy; L Malissard; D Dartois; Elisabeth Luporsi; Joseph Stines; C Chardot
[Natural history and development of bone metastasis. Apropos of 429 cases].
Bulletin du cancer 1988;75(9):845-57.
1987: A Rodde; Joseph Stines; D Regent; S Becker; Thierry Conroy; B Weber; C Delgoffe; C Bour
[Pseudolinitis plastica of breast origin].
Journal de radiologie 1987;68(4):269-74.
1985: J P Aymard; Francis Witz; Thierry Conroy; P Lederlin; J C Humbert; G Barroche; F Streiff
[Acute leukemia secondary to the treatment of multiple sclerosis with chlorambucil].
Revue neurologique 1985;141(2):152-4.
1983: P Lederlin; Francis Witz; J P Aymard; F Rumilly; J C Eisenmann; Thierry Conroy
[Hodgkin's disease in the aged patient. Study of 42 cases].
Presse médicale (Paris, France : 1983) 1983;12(31):1936-7.